About
Biond Biologics develops first-in-class antibody-based immunotherapies targeting immune evasion mechanisms in oncology and immune-mediated diseases, with multiple clinical-stage programs addressing solid tumors.
Explore Biond Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.